ticlopidine has been researched along with Esophageal Reflux in 15 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " PPIs are the mainstay therapeutic agents for prophylaxis against aspirin gastropathy and for acid-related disorders including gastroesophageal reflux disease." | 4.95 | East Asian perspective on the interaction between proton pump inhibitors and clopidogrel. ( Goh, KL; Zou, D, 2017) |
| " Proton pump inhibitors cause few adverse effects with short-term use; however, long-term use has been scrutinized for appropriateness, drug-drug interactions, and the potential for adverse effects (e." | 2.48 | Reducing adverse effects of proton pump inhibitors. ( Ament, PW; Dicola, DB; James, ME, 2012) |
| "Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population." | 1.42 | What are the precautions with proton pump inhibitor use for reflux disease? ( Mospan, CM, 2015) |
| " In study 2, 35 healthy subjects were treated with LDA 100 mg (regimen A), and then 20 randomly selected subjects were dosed clopidogrel 75 mg (regimen C), LDA/clopidogrel (regimen AC), or LDA/clopidogrel/rabeprazole 10 mg for 7 days." | 1.39 | Antiplatelet drugs are a risk factor for esophageal mucosal injury. ( Furuta, T; Miyajima, H; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimoto, M | 1 |
| Uotani, T | 1 |
| Nishino, M | 1 |
| Yamade, M | 1 |
| Sahara, S | 1 |
| Yamada, T | 1 |
| Osawa, S | 1 |
| Sugimoto, K | 1 |
| Umemura, K | 1 |
| Watanabe, H | 1 |
| Miyajima, H | 1 |
| Furuta, T | 1 |
| Mospan, CM | 1 |
| Zou, D | 1 |
| Goh, KL | 1 |
| Gupta, E | 1 |
| Bansal, D | 1 |
| Sotos, J | 1 |
| Olden, K | 1 |
| Sataloff, RT | 1 |
| Madanick, RD | 1 |
| Scholl, S | 1 |
| Dellon, ES | 1 |
| Shaheen, NJ | 1 |
| Greenspan, NR | 1 |
| Schmidt, M | 1 |
| Johansen, MB | 1 |
| Robertson, DJ | 1 |
| Maeng, M | 1 |
| Kaltoft, A | 1 |
| Jensen, LO | 1 |
| Tilsted, HH | 1 |
| Bøtker, HE | 1 |
| Sørensen, HT | 1 |
| Baron, JA | 1 |
| Leontiadis, GI | 1 |
| Howden, CW | 1 |
| Ament, PW | 1 |
| Dicola, DB | 1 |
| James, ME | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Institute of Emergency and Critical Care Medicine , School of Yang-Ming University[NCT01588886] | 9,000 participants (Actual) | Observational | 2012-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for ticlopidine and Esophageal Reflux
| Article | Year |
|---|---|
East Asian perspective on the interaction between proton pump inhibitors and clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anticoagulants; Asia, Eastern; Asian People; Aspirin; Clopi | 2017 |
PPI interactions with clopidogrel.
Topics: Anti-Ulcer Agents; Cardiovascular Diseases; Clopidogrel; Drug Interactions; Gastroesophageal Reflux; | 2009 |
Proton pump inhibitor side effects and drug interactions: much ado about nothing?
Topics: Anemia, Iron-Deficiency; Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Fractures, Spontaneous; | 2011 |
Reducing adverse effects of proton pump inhibitors.
Topics: Anemia, Iron-Deficiency; Clopidogrel; Clostridioides difficile; Critical Care; Diarrhea; Drug Intera | 2012 |
11 other studies available for ticlopidine and Esophageal Reflux
| Article | Year |
|---|---|
Antiplatelet drugs are a risk factor for esophageal mucosal injury.
Topics: Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Aspirin; Case-Control Studies; Clopidogrel; | 2013 |
What are the precautions with proton pump inhibitor use for reflux disease?
Topics: Anemia, Iron-Deficiency; Clopidogrel; Community-Acquired Infections; Deficiency Diseases; Drug Inter | 2015 |
[Proton pump inhibition: more than only reflux therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Asthma; Chest Pain; Clopidogrel; Comorbi | 2008 |
[Taking metabolic pathways into consideration. Approved drug against problematic interactions ].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clopidogr | 2009 |
Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Chi-Square Distribution; Clopidogrel; Cohort Studies; Drug Interacti | 2010 |
Proton pump inhibitors: Adverse effects.
Topics: Calcium; Clopidogrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interacti | 2010 |
Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions.
Topics: Adenocarcinoma; Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Aspirin; Barrett Esop | 2011 |
Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
Topics: Adenocarcinoma; Clopidogrel; Drug Industry; Drug Interactions; Endoscopy, Gastrointestinal; Esophage | 2011 |
Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
Topics: Adult; Aged; Aged, 80 and over; Catheter Ablation; Clopidogrel; Cohort Studies; Cytochrome P-450 Enz | 2012 |
PPI co-therapy did not adversely affect outcomes in clopidogrel users.
Topics: Cytochrome P-450 Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Male; Myocardial Infarc | 2012 |
Side effects of proton pump inhibitors.
Topics: Clopidogrel; Diarrhea; Drug Interactions; Gastroesophageal Reflux; Hip Fractures; Humans; Platelet A | 2012 |